-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Chemours, Lowers Price Target to $20

Benzinga·10/20/2026 16:28:09
Listen to the news
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $24 to $20.